Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03095248
Title Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Children's Hospital Medical Center, Cincinnati
Indications

neurilemmoma

malignant ependymoma

acoustic neuroma

malignant glioma

meningioma

Therapies

Selumetinib

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.